Novonesis
↗Lyngby, Denmark
Novonesis is a global powerhouse in biosolutions, formed in January 2024 through the landmark merger of Novozymes and Chr. Hansen. The company is the world leader in industrial enzymes and microbial solutions, holding approximately 50% market share in both sectors. It operates through two primary divisions: Food & Health Biosolutions and Planetary Health Biosolutions.
Novonesis leverages a vast library of over 50,000 microbial strains and 10,000+ patents to transform how the world produces, consumes, and lives. Its solutions serve more than 30 industries, including household care, food and beverages, bioenergy, agriculture, and human health. The company is controlled by Novo Holdings, the investment arm of the Novo Nordisk Foundation.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Biosolutions (Enzymes & Microbes)
SIZE & FINANCIALS
Employees:10000+
Revenue:$4.1B - $4.6B
Founded:2024
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Novo Holdings (Controlling Shareholder)
STOCK
Exchange:Nasdaq Copenhagen
Ticker:NSIS-B
Market Cap:$28.5B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Probiotics & HMOs)
Modalities:Probiotics, Enzymes, Human Milk Oligosaccharides (HMOs), Postbiotics, Synbiotics
Active Trials:15
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Novo Holdings (Major Shareholder)
Subsidiaries:Novozymes A/S, Chr. Hansen A/S, Feed Enzymes AG
Key Partnerships:Novo Nordisk (Metabolic health research), UC San Diego (HMO research consortium), Noma (Culinary biology collaboration)
COMPETITION
Position:Leader
Competitors:IFF (International Flavors & Fragrances), DSM-Firmenich, Kerry Group, ADM (Archer Daniels Midland)
LEADERSHIP
Key Executives:
Ester Baiget - President & CEO
Rainer Lehmann - CFO
Claus Crone Fuglsang - Chief Scientific Officer
Board Members:Cees de Jong (Chair), Heine Dalsgaard (Vice Chair), Kim Stratton, Morten Otto Alexander Sommer
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Novonesis. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.